BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 9886383)

  • 1. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
    Labeur MS; Roters B; Pers B; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jan; 162(1):168-75. PubMed ID: 9886383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
    Curiel-Lewandrowski C; Mahnke K; Labeur M; Roters B; Schmidt W; Granstein RD; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jul; 163(1):174-83. PubMed ID: 10384114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.
    Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R
    Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
    Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen tension regulates the in vitro maturation of GM-CSF expanded murine bone marrow dendritic cells by modulating class II MHC expression.
    Goth SR; Chu RA; Pessah IN
    J Immunol Methods; 2006 Jan; 308(1-2):179-91. PubMed ID: 16406060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms.
    Mendoza L; Bubeník J; Símová J; Korb J; Bieblová J; Vonka V; Indrová M; Mikysková R; Jandlová T
    Folia Biol (Praha); 2002; 48(3):114-9. PubMed ID: 12118725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice.
    Koike E; Takano H; Inoue K; Yanagisawa R
    Int Immunopharmacol; 2008 Dec; 8(13-14):1737-43. PubMed ID: 18775800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth.
    Mendoza L; Indrová M; Hájková R; Reinis M; Smahel M; Vonka V; Bubeník J; Jandlová T
    Folia Biol (Praha); 2000; 46(3):91-7. PubMed ID: 10925779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freezing and thawing of murine bone marrow-derived dendritic cells does not alter their immunophenotype and antigen presentation characteristics.
    Mendoza L; Bubeník J; Indrová M; Bieblová J; Vonka V; Símová J
    Folia Biol (Praha); 2002; 48(6):242-5. PubMed ID: 12512800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation.
    Matsuzaki J; Tsuji T; Zhang Y; Wakita D; Imazeki I; Sakai T; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):139-47. PubMed ID: 16441425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy.
    Chen Z; Dehm S; Bonham K; Kamencic H; Juurlink B; Zhang X; Gordon JR; Xiang J
    Cell Immunol; 2001 Nov; 214(1):60-71. PubMed ID: 11902830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
    J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.
    Liu KJ; Lu LF; Cheng HT; Hung YM; Shiou SR; Whang-Peng J; Juang SH
    Cancer Gene Ther; 2004 Feb; 11(2):135-47. PubMed ID: 14647233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.
    Miura S; Kagamu H; Tanaka H; Yoshizawa H; Gejyo F
    Scand J Immunol; 2008 Apr; 67(4):385-91. PubMed ID: 18282232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.